Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study record content, signaling that the study page is currently inaccessible.
    Difference
    18%
    Check dated 2026-09-22T23:51:18.000Z thumbnail image
  2. Check
    18 days ago
    No Change Detected
  3. Check
    25 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.6.5 to v3.6.6, reflecting a new metadata version of the page.
    Difference
    0.0%
    Check dated 2026-09-01T19:55:28.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor version update to the page’s documentation or system, with no changes to the study information.
    Difference
    0.0%
    Check dated 2026-08-11T18:30:32.000Z thumbnail image
  5. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, indicating a minor backend or formatting update without changes to study information.
    Difference
    0.0%
    Check dated 2026-07-21T12:38:25.000Z thumbnail image
  6. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now shown, replacing the previous v3.6.0. This appears to be a minor maintenance update to the page’s versioning rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-30T00:39:12.000Z thumbnail image
  7. Check
    103 days ago
    Change Detected
    Summary
    New guidance and navigation sections have been added to help users read the study record and join the study. Recruitment status indicates no longer looking for participants, and the page revision was updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T15:54:37.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.